MedTrace Logo

Research OutSmarts Endometriosis II Study

NCT05601596 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 185

Last updated 2025-03-13

No results posted yet for this study

Summary

This product will be used as a diagnostic test to screen for the likelihood of endometriosis in menstruating adults with symptoms suggestive of endometriosis. The purpose of the test will be to guide clinical decisions regarding: 1) whether to undergo diagnostic laparoscopy to confirm the presence of endometriosis (currently, the gold standard for diagnosing endometriosis) and/or 2) how to guide the choice of hormonal or other therapies to treat symptoms of endometriosis.

Conditions

  • Endometriosis

Interventions

DIAGNOSTIC_TEST

Analysis of menstrual blood to predict endometriosis

Menstrual blood from controls and symptomatic cases will be analyzed using single cell RNA-sequencing to develop a panel of biomarkers that can be developed into a screening test or diagnostic test for endometriosis.

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Peter K Gregersen, MD · Northwell Health

  • Christine N Metz, PhD · Northwell Health

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-27
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05601596 on ClinicalTrials.gov